Human GP39(Glycoprotein 39, Cartilage) CLIA Kit

The Human GP39 (Glycoprotein 39, Cartilage) CLIA Kit is a highly advanced and reliable diagnostic tool designed for the detection and quantification of GP39 in human serum, plasma, and other biological fluids. This kit is based on the Chemiluminescent Immunoassay (CLIA) technology, which offers superior sensitivity, specificity, and accuracy compared to other conventional immunoassay methods.

The GP39 protein is a glycoprotein that is primarily expressed in cartilage tissues and is known to play a crucial role in the pathogenesis of various joint diseases, including rheumatoid arthritis and osteoarthritis. The Human GP39 CLIA Kit is specifically designed to measure the levels of GP39 in human samples, making it an essential tool for the diagnosis and monitoring of joint diseases.

The kit contains all the necessary reagents and components required for the assay, including pre-coated microplates, standards, controls, and detection antibodies. The assay procedure is simple, fast, and can be completed within a short period of time. The results obtained from the assay are highly accurate and reproducible, making it an ideal tool for clinical and research applications.

In summary, the Human GP39 (Glycoprotein 39, Cartilage) CLIA Kit is a highly sensitive and specific diagnostic tool that offers accurate and reliable results for the detection and quantification of GP39 in human samples. It is an essential tool for the diagnosis and monitoring of joint diseases and is suitable for use in clinical and research settings.